Department for Urology

Publications

  1. SCORING: Journal article › Research › Peer-reviewed
  2. The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial

    Gontero, P., Oderda, M., Mehnert, A., Gurioli, A., Marson, F., Lucca, I., Rink, M., Schmid, M., Kluth, L. A., Pappagallo, G., Sogni, F., Sanguedolce, F., Schiavina, R., Martorana, G., Shariat, S. F. & Chun, F., 01.09.2013, In: J UROLOGY. 190, 3, p. 857-62 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis

    Löppenberg, B., Dalela, D., Karabon, P., Sood, A., Sammon, J. D., Meyer, C. P., Sun, M., Noldus, J., Peabody, J. O., Trinh, Q-D., Menon, M. & Abdollah, F., 07.2017, In: EUR UROL. 72, 1, p. 14-19

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. The Impact of Lymph Node Metastases Burden at Radical Prostatectomy

    Preisser, F., Marchioni, M., Nazzani, S., Bandini, M., Tian, Z., Montorsi, F., Saad, F., Abdollah, F., Steuber, T., Heinzer, H., Huland, H., Graefen, M., Tilki, D. & Karakiewicz, P. I., 05.2019, In: EUR UROL FOCUS. 5, 3, p. 399-406 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. The Impact of Repeat Prostate Biopsies on Oncologic, Pathological and Perioperative Outcomes after Radical Prostatectomy

    Rosenbaum, C. M., Mandel, P., Tennstedt, P., Boehm, K., Chun, F. K-H., Graefen, M., Heinzer, H., Tilki, D. & Salomon, G., 01.2017, In: J UROLOGY. 197, 1, p. 103-108 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. The Impact of Resident Involvement in Male One-stage Anterior Urethroplasties

    Meyer, C. P., Hanske, J., Friedlander, D. F., Schmid, M., Dahlem, R., Trinh, V. Q., Chang, S. L., Kibel, A. S., Chun, F. K. H., Fisch, M., Trinh, Q-D. & Eswara, J. R., 01.04.2015, In: UROLOGY. 85, 4, p. 937-41 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population-based study.

    Budäus, L., Abdollah, F., Sun, M., Johal, R., Morgan, M., Thuret, R., Zorn, K. C., Lughezzani, G., Isbarn, H., Haese, A., Shariat, S. F., Montorsi, F., Perrotte, P., Graefen, M. & Karakiewicz, P. I., 2011, In: BJU INT. 108, 6, p. 888-893 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. The Impact of Surgical Sequence on Stricture Recurrence after Anterior 1-Stage Buccal Mucosal Graft Urethroplasty: Comparative Effectiveness of Initial, Repeat and Secondary Procedures

    Vetterlein, M. W., Stahlberg, J., Zumstein, V., Engel, O., Dahlem, R., Fisch, M., Rosenbaum, C. M., Kluth, L. A. & Trauma and Reconstructive Urology Working Party of the European Association of Urology (EAU) Young Academic Urologists (YAU), 12.2018, In: J UROLOGY. 200, 6, p. 1308-1314 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy

    Engel, O., Soave, A., Peine, S., Kluth, L. A., Schmid, M., Shariat, S. F., Dahlem, R., Fisch, M. & Rink, M., 18.03.2015, In: WORLD J UROL. 33, 11, p. 1769-1776

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

    Tennstedt, P., Köster, P., Brüchmann, A., Mirlacher, M., Haese, A., Steuber, T., Sauter, G., Huland, H., Graefen, M., Schlomm, T., Minner, S. & Simon, R., 2012, In: INT J ONCOL. 40, 1, p. 261-268 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. The impact of time to prostate specific antigen nadir on biochemical recurrence and mortality rates after radiation therapy for localized prostate cancer

    Wenzel, M., Dariane, C., Saad, F., Karakiewicz, P. I., Mandel, P., Chun, F. K. H., Tilki, D., Graefen, M., Delouya, G., Taussky, D. & Würnschimmel, C., 02.2022, In: UROL ONCOL-SEMIN ORI. 40, 2, p. 57.e15-57.e23 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration

    Afferi, L., Zamboni, S., Karnes, R. J., Roghmann, F., Sargos, P., Montorsi, F., Briganti, A., Gallina, A., Mattei, A., Schulz, G. B., Hendricksen, K., Voskuilen, C. S., Rink, M., Poyet, C., De Cobelli, O., di Trapani, E., Simeone, C., Soligo, M., Simone, G., Tuderti, G., Alvarez-Maestro, M., Martínez-Piñeiro, L., Aziz, A., Shariat, S. F., Abufaraj, M., Xylinas, E., Moschini, M. & European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group, 02.2021, In: WORLD J UROL. 39, 2, p. 443-451 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy

    Soave, A., John, L-M., Dahlem, R., Minner, S., Engel, O., Schmidt, S., Kluth, L. A., Fisch, M. & Rink, M., 07.2015, In: UROLOGY. 86, 1, p. 92-8 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy

    Marks, P., Gild, P., Soave, A., Janisch, F., Minner, S., Engel, O., Vetterlein, M. W., Shariat, S. F., Sauter, G., Dahlem, R., Fisch, M. & Rink, M., 03.2019, In: SURG ONCOL. 28, p. 208-213 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. The impact of very high initial PSA on oncological outcomes after radical prostatectomy for clinically localized prostate cancer

    Tilki, D., Mandel, P., Karakiewicz, P. I., Heinze, A., Huland, H., Graefen, M. & Knipper, S., 05.2020, In: UROL ONCOL-SEMIN ORI. 38, 5, p. 379-385 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.

    Abdollah, F., Sun, M., Shariat, S. F., Schmitges, J., Djahangirian, O., Tian, Z., Jeldres, C., Perrotte, P., Montorsi, F. & Karakiewicz, P. I., 2011, In: J UROLOGY. 185, 6, p. 2078-2084 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. The influence of marital status on the use of breast, cervical, and colorectal cancer screening

    Hanske, J., Meyer, C. P., Sammon, J. D., Choueiri, T. K., Menon, M., Lipsitz, S. R., Noldus, J., Nguyen, P. L., Sun, M. & Trinh, Q-D., 08.2016, In: PREV MED. 89, p. 140-5 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. The modified Clavien system: a plea for a standardized reporting system for surgical complications.

    Graefen, M., 2010, In: EUR UROL. 57, 3, p. 387-389 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

    Deek, M. P., Van der Eecken, K., Phillips, R., Parikh, N. R., Isaacsson Velho, P., Lotan, T. L., Kishan, A. U., Maurer, T., Boutros, P. C., Hovens, C., Abramowtiz, M., Pollack, A., Desai, N., Stish, B., Feng, F. Y., Eisenberger, M., Carducci, M., Pienta, K. J., Markowski, M., Paller, C. J., Antonarakis, E. S., Berlin, A., Ost, P., Tran, P. T. & GAP6 Consortium, 11.2021, In: EUR UROL. 80, 5, p. 632-640 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. The National Utilization of Non-Operative Management for Small Renal Masses Over 10 Years

    Filipas, D. K., Beatrici, E., Nolazco, J. I., Qian, Z., Marks, P., Labban, M., Stone, B. V., Pierorazio, P. M., Lipsitz, S. R., Trinh, Q-D., Chang, S. L. & Cole, A. P., 31.10.2023, In: JNCI CANCER SPECT. 7, 6, pkad084.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis

    Tully, K. H., Berg, S., Paciotti, M., Janisch, F., Reese, S. W., Noldus, J., Shariat, S. F., Choueiri, T., Müller, G., McGregor, B., Chang, S. L., Trinh, Q-D. & Mossanen, M., 02.2023, In: CLIN GENITOURIN CANC. 21, 1, p. 63-68 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis

    Lucca, I., Jichlinski, P., Shariat, S. F., Rouprêt, M., Rieken, M., Kluth, L. A., Rink, M., Mathieu, R., Mbeutcha, A., Maj-Hes, A., Fajkovic, H., Briganti, A., Seitz, C., Karakiewicz, P. I., de Martino, M., Lotan, Y., Babjuk, M. & Klatte, T., 04.2016, In: EUR UROL FOCUS. 2, 1, p. 79-85 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.

    Budäus, L., Graefen, M., Salomon, G., Isbarn, H., Lughezzani, G., Sun, M., Chun, F., Schlomm, T., Steuber, T., Haese, A., Köllermann, J., Sauter, G., Fisch, M., Heinzer, H., Huland, H. & Karakiewicz, P. I., 2010, In: INT J UROL. 17, 10, p. 862-868 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. The potential role of G2- but not of G0-radiosensitivity for predisposition of prostate cancer.

    Borgmann, K., Raabe, A., Reuther, S., Szymczak, S., Schlomm, T., Isbarn, H., Gomolka, M., Busjahn, A., Bonin, M., Ziegler, A. & Dikomey, E., 2010, In: RADIOTHER ONCOL. 96, 1, p. 19-24 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. The presence of prostate cancer on saturation biopsy can be accurately predicted.

    Ahyai, S., Isbarn, H., Karakiewicz, P. I., Chun, F., Reichert, M., Walz, J., Steuber, T., Jeldres, C., Schlomm, T., Heinzer, H., Salomon, G., Budäus, L., Perrotte, P., Huland, H., Graefen, M. & Haese, A., 2010, In: BJU INT. 105, 5, p. 636-641 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma

    Gakis, G., Schubert, T., Morgan, T. M., Daneshmand, S., Keegan, K. A., Mischinger, J., Clayman, R. H., Brisuda, A., Ali-El-Dein, B., Galland, S., Gregg, J., Balci, M., Olugbade, K., Rink, M., Fritsche, H-M., Burger, M., Babjuk, M., Stenzl, A., Thalmann, G. N., Kübler, H. & Efstathiou, J. A., 01.2018, In: UROL ONCOL-SEMIN ORI. 36, 1, p. 10.e7-10.e14

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

    Grupp, K., Boumesli, R., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Sauter, G., Simon, R., Izbicki, J. R., Graefen, M., Huland, H., Steurer, S., Schlomm, T., Minner, S. & Quaas, A., 15.09.2014, In: INT J CANCER. 135, 6, p. 1399-1407

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy

    Sevcenco, S., Mathieu, R., Baltzer, P., Klatte, T., Fajkovic, H., Seitz, C., Karakiewicz, P. I., Rouprêt, M., Rink, M., Kluth, L., Trinh, Q-D., Loidl, W., Briganti, A., Scherr, D. S. & Shariat, S. F., 06.2016, In: PROSTATE CANCER P D. 19, 2, p. 163-7

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

    Burdelski, C., Menan, D., Tsourlakis, M. C., Kluth, M., Hube-Magg, C., Melling, N., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Simon, R., Schlomm, T., Steurer, S. & Krech, T., 2015, In: BMC CANCER. 15, p. 538

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)

    Janisch, F., D'Andrea, D., Iwata, T., Kimura, S., Abufaraj, M., Enikeev, D., Glybochko, P. V., Karakiewicz, P. I., Nyirady, P., Fajkovic, H., Haitel, A., Seebacher, V., Rink, M. & Shariat, S. F., 05.2020, In: UROL ONCOL-SEMIN ORI. 38, 5, p. 423-432 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

    Ploussard, G., Haese, A., Hendrik, V. P., Marberger, M., Stenzl, A., Mulders, P. F. A., Huland, H., Bastien, L., Abbou, C-C., Remzi, M., Tinzl, M., Feyerabend, S., Stillebroer, A. B., Gils, V., Martijn, P. M. Q., Schalken, J. A. & de La Taille, A., 2010, In: BJU INT. 106, 8, p. 1143-1147 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. [Therapeutic options in hormone refractory prostate carcinoma]

    Graefen, M., Hammerer, P., Haese, A. & Huland, H., 2000, In: UROLOGE. 39, 3, p. 267-273 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Therapieoptionen der rezidivierenden oder persistierenden Belastungsharninkontinenz

    Soave, A., Engel, O., Rink, M., Fisch, M. & Dahlem, R., 01.03.2014, In: UROLOGE. 53, 3, p. 346-353 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Therapy of recurrent disease after radical prostatectomy in 2007.

    Schwarz, R., Graefen, M. & Krüll, A., 2007, In: WORLD J UROL. 25, 2, p. 161-167 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.

    Bhojani, N., Capitanio, U., Nazareno, S., Jeldres, C., Isbarn, H., Shariat, S. F., Graefen, M., Arjane, P., Duclos, A., Lattouf, J-B., Saad, F., Valiquette, L., Montorsi, F., Perrotte, P. & Karakiewicz, P. I., 2010, In: INT J RADIAT ONCOL. 76, 2, p. 342-348 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance.

    van Poppel, H., Haese, A., Graefen, M., de La Taille, A., Irani, J., de Reijke, T., Remzi, M. & Marberger, M., 2012, In: BJU INT. 109, 3, p. 360-366 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Thermal Ablation of Renal Tumors: Indications, Techniques and Results

    Regier, M. & Chun, F., 12.06.2015, In: DTSCH ARZTEBL INT. 112, 24, p. 412-8 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysis.

    Schubert, M., Joniau, S., Gontero, P., Kneitz, S., Scholz, C-J., Kneitz, B., Briganti, A., Karnes, R. J., Tombal, B., Walz, J., Hsu, C-Y., Marchioro, G., Bader, P., Bangma, C., Frohneberg, D., Graefen, M., Schröder, F., van Cangh, P., van Poppel, H. & Spahn, M., 2012, In: ADV UROL. 2012, p. 612707

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?

    Schmid, M., Trinh, Q-D., Graefen, M., Fisch, M., Chun, F. K. & Hansen, J., 01.08.2014, In: WORLD J UROL. 32, 4, p. 871-880 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.

    Haese, A., Graefen, M., Becker, C., Noldus, J., Katz, J., Cagiannos, I., Kattan, M., Scardino, P. T., Huland, E., Huland, H. & Lilja, H., 2003, In: PROSTATE. 54, 3, p. 181-186 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer

    Quhal, F., Rajwa, P., Mori, K., Laukhtina, E., Grossmann, N. C., Schuettfort, V. M., König, F., Aydh, A., Motlagh, R. S., Katayama, S., Mostafai, H., Pradere, B., Marra, G., Gontero, P., Mathieu, R., Karakiewicz, P. I., Briganti, A., Shariat, S. F. & Heidenreich, A., 08.2021, In: PROSTATE. 81, 11, p. 765-771 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate Cancer

    Mandel, P., Kriegmair, M. C., Veleva, V., Salomon, G., Graefen, M., Huland, H. & Tilki, D., 07.2016, In: UROLOGY. 93, p. 141-6 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. The search for biomarkers of metastatic seminoma

    Ruf, C. G., Khalili-Harbi, N., Sachs, S., Isbarn, H., Wagner, W., Matthies, C., Meineke, V., Fisch, M., Chun, F. K. & Abend, M., 01.09.2013, In: J UROLOGY. 190, 3, p. 1046-51 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. The Significance of Primary Biopsy Gleason 5 in Patients with Grade Group 5 Prostate Cancer

    Tilki, D., Würnschimmel, C., Preisser, F., Graefen, M., Huland, H., Mandel, P. & Tennstedt, P., 15.03.2020, In: EUR UROL FOCUS. 6, 2, p. 255-258 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer

    Tosco, L., Laenen, A., Briganti, A., Gontero, P., Karnes, R. J., Albersen, M., Bastian, P. J., Chlosta, P., Claessens, F., Chun, F. K., Everaerts, W., Gratzke, C., Graefen, M., Kneitz, B., Marchioro, G., Salas, R. S., Tombal, B., Van den Broeck, T., Moris, L., Battaglia, A., van der Poel, H., Walz, J., Bossi, A., De Meerleer, G., Haustermans, K., Van Poppel, H., Spahn, M., Joniau, S. & European Multictr Prostate Canc Cl , 12.2017, In: PROSTATE CANCER P D. 20, 4, p. 407-412 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. The T-plasty: a modified YV-plasty for highly recurrent bladder neck contracture after transurethral surgery for benign hyperplasia of the prostate: clinical outcome and patient satisfaction

    Reiss, C. P., Rosenbaum, C. M., Becker, A., Schriefer, P., Ludwig, T. A., Engel, O., Riechardt, S., Fisch, M. & Dahlem, R., 01.10.2016, In: WORLD J UROL. 34, 10, p. 1437-42

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. The T-plasty as therapy for recurrent bladder neck stenosis: success rate, functional outcome, and patient satisfaction

    Rosenbaum, C. M., Dahlem, R., Maurer, V., Kluth, L. A., Vetterlein, M. W., Fisch, M., Schuettfort, V. & Reiss, C. P., 12.2017, In: WORLD J UROL. 35, 12, p. 1907-1911

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. The Urologist's Role in Antibiotic Stewardship: Results from the MR2 Study

    Lebentrau, S., Vetterlein, M. W. & May, M., 06.2017, In: EUR UROL. 71, 6, p. 995-996

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians

    Martini, T., Gilfrich, C., Mayr, R., Burger, M., Pycha, A., Aziz, A., Gierth, M., Stief, C. G., Müller, S. C., Wagenlehner, F., Roigas, J., Hakenberg, O. W., Roghmann, F., Nuhn, P., Wirth, M., Novotny, V., Hadaschik, B., Grimm, M-O., Schramek, P., Haferkamp, A., Colleselli, D., Kloss, B., Herrmann, E., Fisch, M., May, M. & Bolenz, C., 06.2017, In: CLIN GENITOURIN CANC. 15, 3, p. 356-362

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy

    Mori, K., Schuettfort, V. M., Katayama, S., Laukhtina, E., Pradere, B., Quhal, F., Sari Motlagh, R., Mostafaei, H., Grossmann, N. C., Rajwa, P., König, F., Aydh, A., Soria, F., Moschini, M., Karakiewicz, P. I., Lotan, Y., Scherr, D., Haydter, M., Nyirady, P., Teoh, J. Y. C., Egawa, S., Compérat, E. & Shariat, S. F., 07.2022, In: EUR UROL FOCUS. 8, 4, p. 972-979 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. [The value of real-time elastography in the diagnosis of prostate cancer]

    Salomon, G., Graefen, M., Heinzer, H., Huland, H., Pallwein, L., Aigner, F. & Frauscher, F., 2009, In: UROLOGE. 48, 6, p. 628-636 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy.

    Isbarn, H., Jeldres, C., Capitanio, U., Zini, L., Shariat, S. F., Lughezzani, G., Sun, M., Ahyai, S. A., Duclos, A., Jolivet-Tremblay, M., Lattouf, J-B., Valiquette, L., Perrotte, P., Montorsi, F., Graefen, M. & Karakiewicz, P. I., 2009, In: J ENDOUROL.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Timing of curative treatment for prostate cancer: a systematic review

    van den Bergh, R. C. N., Albertsen, P. C., Bangma, C. H., Freedland, S. J., Graefen, M., Vickers, A. & van der Poel, H. G., 01.08.2013, In: EUR UROL. 64, 2, p. 204-15 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. "Tissue engineering" in der rekonstruktiven Urologie

    Engel, O., Soave, A., Rink, M., Dahlem, R., Hellwinkel, O., Chun, F. K. & Fisch, M., 20.02.2015, In: UROLOGE. 54, 5, p. 690-695

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  55. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.

    Haubold, K., Rink, M., Spath, B., Friedrich, M., Chun, F., Marx, G., Amirkhosravi, A., Francis, J. L., Bokemeyer, C., Eifrig, B. & Langer, F., 2009, In: THROMB HAEMOSTASIS. 101, 6, p. 1147-1155 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  56. TMPRSS2-ERG Fusions Are Strongly Linked to Young Patient Age in Low-grade Prostate Cancer

    Steurer, S., Mayer, P. S., Adam, M., Krohn, A., Koop, C., Ospina-Klinck, D., Tehrani, A. A., Simon, R., Tennstedt, P., Graefen, M., Wittmer, C., Brors, B., Plass, C., Korbel, J., Weischenfeldt, J., Sauter, G., Huland, H., Tsourlakis, M. C., Minner, S. & Schlomm, T., 08.07.2014, In: EUR UROL. 66, 6, p. 978-981

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  57. TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis.

    Rostad, K., Hellwinkel, O., Haukaas, S. A., Halvorsen, O. J., Øyan, A. M., Haese, A., Budäus, L., Albrecht, H., Akslen, L. A., Schlomm, T. & Kalland, K-H., 2009, In: APMIS. 117, 8, p. 575-582 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  58. TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling.

    Brase, J. C., Johannes, M., Mannsperger, H., Fälth, M., Metzger, J., Kacprzyk, L. A., Andrasiuk, T., Gade, S., Meister, M., Sirma, H., Sauter, G., Simon, R., Schlomm, T., Beissbarth, T., Korf, U., Kuner, R. & Sültmann, H., 2011, In: BMC CANCER. 11, p. 507

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  59. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

    Haese, A., Graefen, M., Steuber, T., Becker, C., Noldus, J., Erbersdobler, A., Huland, E., Huland, H. & Lilja, H., 2003, In: J UROLOGY. 170(6 Pt 1), p. 2269-2273

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  60. Total, free and complexed PSA and hK2 for early detection of prostate cancer.

    Haese, A., Khan, M. A. & Sokoll, L. J., 2003, In: MLO Med Lab Obs. 35, 6, p. 14-16, 20, 30-31 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  61. Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer

    Löser, A., Beyer, B., Carl, C. O., Löser, B., Nagaraj, Y., Frenzel, T., Petersen, C., Krüll, A., Graefen, M. & Schwarz, R., 05.2019, In: STRAHLENTHER ONKOL. 195, 5, p. 374-382 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  62. Training, Research, and Working Conditions for Urology Residents in Germany: A Contemporary Survey

    Borgmann, H., Arnold, H. K., Meyer, C. P., Bründl, J., König, J., Nestler, T., Ruf, C., Struck, J. & Salem, J., 04.2018, In: EUR UROL FOCUS. 4, 3, p. 455-460 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  63. Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma.

    Hellwinkel, O., Asong, LE., Rogmann, J-P. J., Sültmann, H., Wagner, C., Schlomm, T. & Eichelberg, C., 2011, In: PROSTATE CANCER P D. 14, 1, p. 38-45 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  64. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.

    Steuber, T., Karakiewicz, P. I., Augustin, H., Erbersdobler, A., Lange, I., Haese, A., Chun, K-H. F., Walz, J., Graefen, M. & Huland, H., 2005, In: J UROLOGY. 173, 3, p. 737-741 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  65. Transperineal reanastomosis for the treatment for highly recurrent anastomotic strictures as a last option before urinary diversion

    Reiß, C-P., Pfalzgraf, D., Kluth, L. A., Soave, A., Fisch, M. & Dahlem, R., 29.10.2013, In: WORLD J UROL.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  66. Transperineal reanastomosis for treatment of highly recurrent anastomotic strictures after radical retropubic prostatectomy: extended follow-up

    Schüttfort, V., Dahlem, R., Kluth, L. A., Pfalzgraf, D., Rosenbaum, C., Ludwig, T. A., Fisch, M. & Reiß, C-P., 12.2017, In: WORLD J UROL. 35, 12, p. 1885-1890 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  67. Transperitoneal laparoscopic adrenalectomy: outline of the preoperative management, surgical approach, and outcome.

    Zacharias, M., Haese, A., Jurczok, A., Stolzenburg, J-U. & Fornara, P., 2006, In: EUR UROL. 49, 3, p. 448-459 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  68. [Transrectal ultrasound-guided punch biopsies of the prostate. Indication, technique, results, and complications]

    Palisaar, J., Eggert, T., Graefen, M., Haese, A. & Huland, H., 2003, In: UROLOGE. 42, 9, p. 1188-1195 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  69. Transurethral holmium laser enucleation versus transurethral resection of the prostate and simple open prostatectomy--which procedure is faster?

    Ahyai, S. A., Chun, F. K. H., Lehrich, K., Dahlem, R., Zacharias, M. S., Fisch, M. M. & Kuntz, R. M., 05.2012, In: J UROLOGY. 187, 5, p. 1608-1613 6 p., 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  70. Traumatische Harnröhrenverletzung--Primär endoskopische versus konservative Therapie

    Dahlem, R., 04.2016, In: AKTUEL UROL. 47, 2, p. 118-9 2 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  71. Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data

    Janisch, F., Kienapfel, C., Fühner, C., Klotzbücher, T., Marks, P., Hillemacher, T., Meyer, C. P., Iwata, T., Parizi, M. K., Sauter, G., Fisch, M., Shariat, S. F., Dahlem, R. & Rink, M., 2021, In: FRONT SURG. 8, 763271.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  72. Treatment of localized prostate cancer.

    Burchardt, M. & Huland, H., 2007, In: WORLD J UROL. 25, 1, p. 1-2 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  73. Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel-A Real-world Data Assessment

    Tsaur, I., Heidegger, I., van den Bergh, R. C. N., Bektic, J., Borgmann, H., Foti, S., Hunting, J. C. B., Kretschmer, A., Ploussard, G., Tilki, D., Gandaglia, G., Dotzauer, R. & EAU-YAU Prostate Cancer Working Group, 11.2021, In: EUR UROL FOCUS. 7, 6, p. 1308-1315 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  74. Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps.

    Hautmann, S., Huland, E., Wullbrand, A., Friedrich, M. & Huland, H., 2000, In: ANTICANCER RES. 20, 6, p. 4495-4498 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  75. Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core

    Hoeh, B., Flammia, R. S., Hohenhorst, L., Sorce, G., Chierigo, F., Tian, Z., Saad, F., Gallucci, M., Briganti, A., Terrone, C., Shariat, S. F., Graefen, M., Tilki, D., Kluth, L. A., Mandel, P., Chun, F. K. H. & Karakiewicz, P. I., 09.2022, In: UROL ONCOL-SEMIN ORI. 40, 9, p. 407.e9-407.e19

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  76. Treatment Strategies and Outcome of the Exstrophy-Epispadias Complex in Germany: Data From the German CURE-Net

    Ebert, A-K., Zwink, N., Reutter, H. M., Jenetzky, E., Stein, R., Hölscher, A. C., Lacher, M., Fortmann, C., Obermayr, F., Fisch, M., Mortazawi, K., Schmiedeke, E., Promm, M., Hirsch, K., Schäfer, F-M. & Rösch, W. H., 2020, In: FRONT PEDIATR. 8, p. 174

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  77. Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies

    Mazzone, E., Knipper, S., Mistretta, F. A., Palumbo, C., Tian, Z., Gallina, A., Tilki, D., Shariat, S. F., Montorsi, F., Saad, F., Briganti, A. & Karakiewicz, P. I., 01.11.2019, In: J NATL COMPR CANC NE. 17, 11, p. 1344-1352 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  78. Trends in surgical management of T1 renal cell carcinoma

    Schiffmann, J., Bianchi, M., Sun, M. & Becker, A., 12.01.2014, In: CURR UROL REP. 15, 2, p. 383

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  79. Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma

    Schmid, M., Krishna, N., Ravi, P., Meyer, C. P., Becker, A., Dalela, D., Sood, A., Chun, F. K-H., Kibel, A. S., Menon, M., Fisch, M., Trinh, Q-D. & Sun, M., 07.2016, In: UROL ONCOL-SEMIN ORI. 34, 7, p. 293.e1-293.e10

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  80. Trends of Metastasis-Directed Treatments in Patients with Renal Cell Carcinoma: A Total Population-Based Analysis in Germany in the Era of Targeted Therapies

    Meyer, C. P., Groeben, C., Marks, P., Koch, R. & Huber, J., 2020, In: ONCOL RES TREAT. 43, 12, p. 679-685 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  81. Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.

    Sun, M., Abdollah, F., Budäus, L., Liberman, D., Tian, Z., Morgan, M., Johal, R., Schmitges, J., Shariat, S. F., Montorsi, F., Graefen, M., Perrotte, P. & Karakiewicz, P. I., 2011, In: ANN SURG ONCOL. 18, 10, p. 2997-3004 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  82. True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts

    Schiffmann, J., Mehring, G., Tennstedt, P., Manka, L., Boehm, K., Leyh-Bannurah, S-R., Karakiewicz, P. I., Hammerer, P., Graefen, M. & Salomon, G., 04.2016, In: WORLD J UROL. 34, 4, p. 495-500 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  83. Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer

    Joosse, S. A., Beyer, B., Gasch, C., Nastały, P., Kuske, A., Isbarn, H., Horst, L. J., Hille, C., Gorges, T. M., Cayrefourcq, L., Alix-Panabières, C., Tennstedt, P., Riethdorf, S., Schlomm, T. & Pantel, K., 01.01.2020, In: CLIN CHEM. 66, 1, p. 161-168 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  84. Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer

    Möller, K., Fraune, C., Blessin, N. C., Lennartz, M., Kluth, M., Hube-Magg, C., Lindhorst, L., Dahlem, R., Fisch, M., Eichenauer, T., Riechardt, S., Simon, R., Sauter, G., Büscheck, F., Höppner, W., Matthies, C., Doh, O., Krech, T., Marx, A. H., Zecha, H., Rink, M., Steurer, S. & Clauditz, T. S., 12.2021, In: INT UROL NEPHROL. 53, 12, p. 2493-2503 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  85. Tumor Characteristics and Oncologic Outcome after Radical Prostatectomy in Men 75 Years Old or Older

    Mandel, P., Kriegmair, M. C., Kamphake, J. K., Chun, F. K-H., Graefen, M., Huland, H. & Tilki, D., 07.2016, In: J UROLOGY. 196, 1, p. 89-94 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  86. Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age

    Tilki, D., Maurer, V., Pompe, R. S., Chun, F. K., Preisser, F., Haese, A., Graefen, M., Huland, H. & Mandel, P., 01.2020, In: WORLD J UROL. 38, 1, p. 95-101 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  87. Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study

    Pompe, R. S., Smith, A., Bandini, M., Marchioni, M., Martel, T., Preisser, F., Leyh-Bannurah, S-R., Schiffmann, J., Saad, F., Huland, H., Graefen, M., Shariat, S. F., Tilki, D. & Karakiewicz, P. I., 04.2018, In: PROSTATE CANCER P D. 21, 1, p. 71-77 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  88. Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.

    Thuret, R., Sun, M., Abdollah, F., Budäus, L., Lughezzani, G., Liberman, D., Morgan, M., Johal, R., Jeldres, C., Latour, M., Shariat, S. F., Iborra, F., Guiter, J., Patard, J-J., Perrotte, P. & Karakiewicz, P. I., 2011, In: J UROLOGY. 185, 2, p. 501-507 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  89. Tumor size and invasiveness matters for partial nephrectomy: External validation and modification of the arterial based complexity score

    Kriegmair, M. C., Hetjens, S., Mandel, P., Wadle, J., Budjan, J., Michel, M. S., Pfalzgraf, D. & Wagener, N., 05.2017, In: J SURG ONCOL. 115, 6, p. 768-774

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  90. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.

    Lughezzani, G., Jeldres, C., Isbarn, H., Perrotte, P., Shariat, S. F., Sun, M., Widmer, H., Arjane, P., Peloquin, F., Pharand, D., Patard, J-J., Graefen, M., Montorsi, F. & Karakiewicz, P. I., 2009, In: J UROLOGY. 182, 4, p. 1287-1293 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  91. Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins

    Meyer, C. P., Hansen, J., Boehm, K., Tilki, D., Abdollah, F., Trinh, Q-D., Fisch, M., Sauter, G., Graefen, M., Huland, H., Chun, F. K. H. & Ahyai, S. A., 02.2017, In: WORLD J UROL. 35, 2, p. 199-206 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  92. Tumor volume in insignificant prostate cancer: increasing threshold gains increasing risk

    Schiffmann, J., Connan, J., Salomon, G., Boehm, K., Beyer, B., Schlomm, T., Tennstedt, P., Sauter, G., Karakiewicz, P. I., Graefen, M. & Huland, H., 01.01.2015, In: PROSTATE. 75, 1, p. 45-9 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  93. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.

    Chun, F., Briganti, A., Jeldres, C., Gallina, A., Erbersdobler, A., Schlomm, T., Walz, J., Eichelberg, C., Salomon, G., Haese, A., Eichelberg, E., Ahyai, S., Bénard, F., Huland, H., Graefen, M. & Karakiewicz, P. I., 2007, In: EUR J CANCER. 43, 3, p. 536-543 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  94. Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort

    Würnschimmel, C., Kachanov, M., Wenzel, M., Mandel, P., Karakiewicz, P. I., Maurer, T., Steuber, T., Tilki, D., Graefen, M. & Budäus, L., 09.2021, In: PROSTATE. 81, 12, p. 849-856 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  95. Two-staged urethroplasty: buccal mucosa and mesh graft techniques.

    Pfalzgraf, D., Olianas, R., Schreiter, F. & Fisch, M., 2010, In: AKTUEL UROL. 41, 1, p. 5-9 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  96. Two-stage urethroplasty with buccal mucosa

    Riechardt, S. & Fisch, M., 01.2012, In: BJU INT. 109, 1, p. 150-162 13 p., 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  97. [Type and extent of preoperative imaging before radical prostatectomy].

    Isbarn, H., Kellermann, S., Salomon, G., Steuber, T., Huland, H. & Graefen, M., 2010, In: UROLOGE. 49, 3, p. 396-400 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  98. UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation

    Itkonen, H. M., Engedal, N., Babaie, E., Luhr, M., Guldvik, I. J., Minner, S., Hohloch, J., Tsourlakis, M. C., Schlomm, T. & Mills, I. G., 01.07.2015, In: ONCOGENE. 34, 28, p. 3744-50

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  99. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.

    Ummanni, R., Jost, E., Balabanov, M., Lohmann, F., Mundt, F., Barett, C., Schlomm, T., Sauter, G., Senff, T., Bokemeyer, C., Sültmann, H., Meyer-Schwesinger, C., Brümmendorf, T. & Balabanov, S., 2011, In: MOL CANCER. 10, p. 129

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  100. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.

    Haese, A., Huland, E., Graefen, M., Hammerer, P., Noldus, J. & Huland, H., 1999, In: J UROLOGY. 161, 4, p. 1206-1211 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review